Focus

Neuroscience Investors: Angels and VC Firms

The RaiseHunt database lists 144 Neuroscience investors: 85 angel investors and 59 people at 23 firms. Most list Seed and Series A among their stages; the largest hubs are Boston, San Francisco and London.

Strongest in Boston, San Francisco and London

Common stages: Seed and Series A

144
Neuroscience investors
85
Angel investors
59
People at VC/PE firms
23
Firms tagged

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

144 Neuroscience investors

Showing 1-20

Filters
Ross Youngs
Ross Youngs

CEO & Co-Founder

Dublin, United States
AngelOperator angel
ClimateHealthcare
View profile
Jordan Curnes
Jordan Curnes

Co-Founder

Milwaukee, United States
AngelOperator angel
ConsumerHardware
View profile
Evan Schwartz
Evan Schwartz

Board Observer

Boston, United States
AngelOperator angel
AIHealthcare
View profile
Olivier Njamfa
Olivier Njamfa

Startup Investor

Paris, France
AngelOperator angel
HealthcareSaaS
View profile
Rajul Jain
Rajul Jain

Managing Director

Santa Monica, United States
Angel
Healthcare
View profile
Stuart Lewtan
Stuart Lewtan

angel investor and operator angel

Boston, United States
AngelOperator angel
EducationHealthcare
View profile
Joe Kraus
Joe Kraus

angel investor and operator angel

Palo Alto, United States
AngelOperator angel
ClimateHealthcare
View profile
Josh Wolfe
Josh Wolfe

angel investor and operator angel

New York City, United States
AngelOperator angel
AIFinTech
View profile
Zach Piester
Zach Piester

angel investor

Atlanta, United States
Angel
AIConsumer
View profile
Erik Qualman
Erik Qualman

angel investor

Austin, United States
Angel
EducationFinTech
View profile
Finn Age Hänsel
Finn Age Hänsel

angel investor and operator angel

Berlin, Germany
AngelOperator angel
CommerceConsumer
View profile
Alice Zhang
Alice Zhang

angel investor and operator angel

San Francisco, United States
AngelOperator angel
AIHealthcare
View profile
Jake Winebaum
Jake Winebaum

angel investor and operator angel

Santa Monica, United States
AngelOperator angel
FinTechHealthcare
View profile
Jess Smith
Jess Smith

angel investor

Sydney, Australia
Angel
Healthcare
View profile
Jannah Boudreaux
Jannah Boudreaux

angel investor

Los Angeles, United States
Angel
AIConsumer
View profile
Imran Eba
Imran Eba

angel investor

Boston, United States
Angel
Healthcare
View profile
Harry Nelson
Harry Nelson

angel investor and operator angel

Los Angeles, United States
AngelOperator angel
HealthcareSaaS
View profile
Adam Gazzaley
Adam Gazzaley

angel investor and operator angel

San Francisco, United States
AngelOperator angel
AIHardware
View profile
Jerry Neumann
Jerry Neumann

angel investor

New York, United States
Angel
AIHealthcare
View profile
James Hyland
James Hyland

angel investor and operator angel

Carmen, United States
AngelOperator angel
AIConsumer
View profile

104 of 144 Neuroscience investors, A to Z

Grouped by first letter. Name and profile link only, the detailed rows are in the table above.
Show

A12

  • Aaqil Anwar
  • Adam Koppel
  • Adam Lessler
  • Adrien Cohen
  • Alan O'Connell
  • Alejandro Sanchez
  • Alice Chen
  • Ami Lebendiker
  • Anatoly Tikhman
  • Andrew Firlik
  • Andrew Krowne
  • Anne Grahl

B4

  • Barbara T.
  • Brandon Drew
  • Brian Mulhall
  • Brian Paegel

C1

  • Cheryl Zimberlin

D10

  • D.A. Wallach
  • David Baszucki
  • David Chappill
  • David Fahrenkamp
  • Debra Liebert
  • Dirk Landgraf
  • Dominik Escher
  • Douglas Talbert
  • Dragan Grabulovski
  • Dusan Perovic

E1

  • Emmanuel Lange

G2

  • George Whitehead
  • German Lemonnier

H1

  • Hyunsun R.

I2

  • Ian Garland
  • Ian Howes

J14

  • Jake Nunn
  • Jasmina Marjanovic
  • Jeanne Bolger
  • Jim Lang
  • Jim Wicks
  • Jitendra Patel
  • John F. Harris
  • John Lee
  • John Lee
  • Jonathan Behr
  • Joshua Cowgill
  • Joshua Greene
  • Joshua Rosamond
  • Julie Gionfriddo

K7

  • Karen Chan
  • Karen Gill
  • Katherine Terranova
  • Ken Mariash
  • Kiran Dallenbach
  • Klaus Breiner
  • Krishnan Akhileswaran

L9

  • Larry Brownstein
  • Lars Nieba
  • Laurent Alexandre
  • Lawrence Bloch
  • Lekan Wang
  • Liam Bradley
  • Liam Ratcliffe
  • Lin Ning
  • Lowell Sears

M10

  • Martin Münchbach
  • Matt D.
  • Maurice R Ferre
  • Maurice Zauderer
  • Merika Koday
  • Michael Dearing
  • Michal Tsur
  • Milad Alucozai
  • Miles Gerson
  • Milton Boniuk

N1

  • Ned Scheetz

P3

  • Pamela Walker Geddes
  • Pascal Levensohn
  • Paul Fauset

R5

  • R. Jordan Hall
  • Rajat Malhotra
  • Reetika B.
  • Ricardo Dolmetsch
  • Ron Rymon

S8

  • Sam Fennell
  • Scott Blumberg
  • Scott Brun
  • Scott Wharton
  • Shailesh Maingi
  • Simon Blakey
  • Sina Ataherian
  • Sina Habibi

T7

  • Thomas Kodadek
  • Thomas Putter
  • Thong Le
  • Tianqiao Chen
  • Tim Barberich
  • Tim Rosa
  • Timothy Mills

V2

  • Veronica Gambillara Fonck
  • Vilas Dhar

W3

  • Walter Carrion
  • Walter Gilbert
  • Will Vicars

X1

  • Ximing Ding

Z1

  • Zack Lynch

Frequently asked questions

How many Neuroscience investors are on RaiseHunt?

RaiseHunt currently lists 144 Neuroscience investors.

Are Neuroscience investors angels or funds?

Both. 85 are angel investors putting in their own money, and 59 are people making investment decisions at 23 firms.

Where are most Neuroscience investors based?

The largest concentrations are in Boston, San Francisco and London.

What stage do Neuroscience investors invest at?

Most list Seed and Series A among the rounds they take part in.

How do I contact Neuroscience investors?

Every profile shows whether an email address is on file. The addresses themselves, along with AI matching and outreach, are in the RaiseHunt app.

Is the list of Neuroscience investors free to browse?

Yes. The directory and every profile page are free to read. Matching your own startup against them requires an account.

Do Neuroscience investors only back Neuroscience companies?

No. A focus area is a signal of interest, not a restriction. Investors usually list several, and the useful question is whether their existing portfolio looks like the kind of company you are building.

What is the difference between an angel investor and a VC fund?

An angel invests their own money and can decide alone, which usually makes the process shorter. A fund invests money it raised from other people, so it answers to those backers and normally runs a longer diligence process before it commits. Founders often raise from angels first and bring in a fund once there is more to show.

How many Neuroscience investors should I contact?

Far more than feels comfortable. Response rates on cold outreach are low even when the fit is good, so a list of a handful of perfect names tends to stall. Build a long list, sort it by how well each one matches what you are building, and work down it in batches rather than sending everything at once.

What should I have ready before reaching out?

A short deck, a one-paragraph description of what you do and who it is for, and a clear number for how much you are raising. Investors read the first two lines before they decide whether to open the deck, so those lines matter more than the rest of the document.

Does a warm introduction still matter?

It helps, mostly because it moves your email out of a crowded inbox. It is not a requirement. A cold message that shows you understand what someone has already backed, and why your company fits that pattern, gets read more often than a vague introduction from a distant contact.

How do I know which Neuroscience investors are a fit?

Look at what they have already funded rather than what their profile says they like. Stage matters most, then sector, then geography. An investor who has never funded anything at your stage is unlikely to start with you, however well the sector lines up.

Data: RaiseHunt investor dataset · Snapshot 27 August 2026 · How this data is built · Report a correction or request removal